Perceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...
The study provides a current perspective of the capabilities in genetics and cell biology which have evolved in the last decade and which appear to be of significance for the next decade.
This Congressional Research Service report on selected strategic issues of interest to Congress, while emphasizing energy policy issues, also contains chapters on issue areas which interrelate-transportation, communication, water, agriculture, etc. There are also a limited number of chapters focusing on issue areas of general interest to Congress-governmental and institutional, education, values and demographics, etc. The report is a major interdisciplinary effort on the part of the Congressional Research Service. It represents the work of five research divisions, eight senior specialists, thirty-eight other specialists and analysts, and the strong support of their two service divisions.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.